MedTrace Logo

Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease)

NCT04649931 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2021-05-03

No results posted yet for this study

Summary

Breath gas analysis is the evaluation of exhaled breath. It aims to evaluate the volatile organic compounds (VOCs) in exhaled breath.

In this feasibility study it is intended to find specific peaks/pattern in exhaled breath indicating an infection with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2).

Conditions

  • SARS (Severe Acute Respiratory Syndrome)
  • Covid19

Interventions

DEVICE

Ion Mobility Spectrometry (IMS)

Two breathing gas samples will be taken from each study participant using ion mobility spectrometry with an ultrasound-based spirometer. The total sampling time is 1 minute (at least 5-7 breath takes) following an analysis time of 5-12 minutes.

Sponsors & Collaborators

  • CeGaT GmbH

    collaborator UNKNOWN

  • B. Braun Melsungen AG

    lead INDUSTRY

Principal Investigators

  • Juergen Schaefer, Prof. Dr. · University Hospital Marburg, Zentrum für unerkannte und seltene Erkrankungen (ZusE)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-14
Primary Completion
2021-04-25
Completion
2021-04-25

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04649931 on ClinicalTrials.gov